NPEC-caged-D-AP5CAS# 1416943-27-5 |
- Mibefradil
Catalog No.:BCC1748
CAS No.:116644-53-2
- Mibefradil dihydrochloride
Catalog No.:BCC1749
CAS No.:116666-63-8
- Cilnidipine
Catalog No.:BCC1083
CAS No.:132203-70-4
- Pregabalin
Catalog No.:BCN2175
CAS No.:148553-50-8
- NNC 55-0396
Catalog No.:BCC1803
CAS No.:357400-13-6
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 1416943-27-5 | SDF | Download SDF |
| PubChem ID | 85757793 | Appearance | Powder |
| Formula | C14H19N2O9P | M.Wt | 390.28 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 100 mM in water and to 100 mM in DMSO | ||
| Chemical Name | 2-[1-(2-nitrophenyl)ethoxycarbonylamino]-5-phosphonopentanoic acid | ||
| SMILES | CC(C1=CC=CC=C1[N+](=O)[O-])OC(=O)NC(CCCP(=O)(O)O)C(=O)O | ||
| Standard InChIKey | RLEANJAZNZWLHC-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C14H19N2O9P/c1-9(10-5-2-3-7-12(10)16(20)21)25-14(19)15-11(13(17)18)6-4-8-26(22,23)24/h2-3,5,7,9,11H,4,6,8H2,1H3,(H,15,19)(H,17,18)(H2,22,23,24) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | D-AP5 caged with the photosensitive 1-(2-nitrophenyl)ethoxycarbonyl (NPEC) group. NMDA receptor antagonist. |
NPEC-caged-D-AP5 Dilution Calculator
NPEC-caged-D-AP5 Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.5623 mL | 12.8113 mL | 25.6226 mL | 51.2453 mL | 64.0566 mL |
| 5 mM | 0.5125 mL | 2.5623 mL | 5.1245 mL | 10.2491 mL | 12.8113 mL |
| 10 mM | 0.2562 mL | 1.2811 mL | 2.5623 mL | 5.1245 mL | 6.4057 mL |
| 50 mM | 0.0512 mL | 0.2562 mL | 0.5125 mL | 1.0249 mL | 1.2811 mL |
| 100 mM | 0.0256 mL | 0.1281 mL | 0.2562 mL | 0.5125 mL | 0.6406 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Thrombin Receptor Activator for Peptide 5 (TRAP-5)
Catalog No.:BCC1025
CAS No.:141685-53-2
- Ivangustin
Catalog No.:BCN3507
CAS No.:14164-59-1
- GR 94800
Catalog No.:BCC5799
CAS No.:141636-65-9
- CU CPT 22
Catalog No.:BCC6320
CAS No.:1416324-85-0
- Dronedarone
Catalog No.:BCN2176
CAS No.:141626-36-0
- (±)-BI-D
Catalog No.:BCC5537
CAS No.:1416258-16-6
- Dronedarone HCl
Catalog No.:BCC4777
CAS No.:141625-93-6
- Beta-D-glucopyranosyl oleanolate
Catalog No.:BCN6530
CAS No.:14162-53-9
- JW 642
Catalog No.:BCC6324
CAS No.:1416133-89-5
- UNC1215
Catalog No.:BCC2023
CAS No.:1415800-43-9
- Angustin B
Catalog No.:BCN7652
CAS No.:1415795-51-5
- Angustin A
Catalog No.:BCN7651
CAS No.:1415795-50-4
- Galanin (2-29) (rat)
Catalog No.:BCC5763
CAS No.:141696-11-9
- Faropenem daloxate
Catalog No.:BCC1571
CAS No.:141702-36-5
- RI-2
Catalog No.:BCC6424
CAS No.:1417162-36-7
- H-Phe(4-Cl)-OH
Catalog No.:BCC3171
CAS No.:14173-39-8
- H-DL-Phe(4-Cl)-OMe.HCl
Catalog No.:BCC3175
CAS No.:14173-40-1
- Exenatide acetate
Catalog No.:BCN8514
CAS No.:141732-76-5
- MM-102
Catalog No.:BCC4551
CAS No.:1417329-24-8
- SDZ SER 082 fumarate
Catalog No.:BCC6994
CAS No.:1417343-80-6
- Exendin-4
Catalog No.:BCC1568
CAS No.:141758-74-9
- Albatrelin A
Catalog No.:BCN7626
CAS No.:1417805-15-2
- Albatrelin C
Catalog No.:BCN7591
CAS No.:1417805-17-4
- Stauntosaponin A
Catalog No.:BCN6966
CAS No.:1417887-91-2
Activation of NMDA receptors is necessary for the induction of associative long-term potentiation in area CA1 of the rat hippocampal slice.[Pubmed:9365912]
J Physiol. 1997 Oct 15;504 ( Pt 2):379-85.
1. It is commonly assumed that the role of the strongly activated heterosynaptic input during the induction of associative long-term potentiation (LTP) is to relieve the magnesium blockade of NMDA receptors located at the weakly stimulated synapses and thereby allow the weak input to undergo potentiation. We tested this assumption by using a caged form of the NMDA receptor antagonist, D-(-)-2-amino-5-phosphonopentanoic acid (D-AP5) to block the activation of NMDA receptors at the weak input in a conditioning protocol for the induction of associative LTP in area CA1 of the rat hippocampal slice. 2. The effect of releasing D-AP5 by flash photolysis of 100 microM caged D-AP5 (N-[1-(2-nitrophenyl)ethoxycarbonyl]-D-AP5) on pharmacologically isolated NMDA receptor-mediated field EPSPs was examined in area CA1. The slope of the EPSP was reduced by 71% within 50 ms of the initiation of the photolytic reaction when the concentration of released D-AP5 had reached 2.0-2.5 microM and was reduced by 95% within 1 min (10 microM D-AP5 released). 3. Associative LTP was induced by pairing a strong tetanus to one input with a weak tetanus (subthreshold for homosynaptic LTP) to a second input. The strong tetanus preceded the weak by 50 ms. Rapid application of D-AP5, by flash photolysis of caged D-AP5, coincident with the last shock of the strong tetanus, resulted in the blockade of NMDA receptor activation during the period of the weak tetanus. Associative LTP was blocked by photolysis of caged D-AP5 but was normally expressed in experiments using caged L-AP5. 4. We conclude that activation of NMDA receptors at the weakly activated input is an essential requirement for synaptically induced associative LTP.
